Plasmapheresis - Technical aspects and indications
Plasmapheresis - Technical aspects and indications
复制标题
DOI:
10.1016/s0749-0704(01)00010-0
复制
发表时间:
2002-04-01
影响因子:
4.3
通讯作者:
Madore, F
中科院分区:
文献类型:
--
作者:
Madore, F
Table 1 summarizes some potentially beneficial actions of plasmapheresis. Plasmapheresis is often employed to rapidly lower circulating titers of autoantibodies (e.g., anti-glomerular basement membrane disease) or immune complexes (e.g., lupus nephritis) [46]. Plasmapheresis has also been proposed as a useful adjunct to chemotherapy for removing circulating immunoglobulins or immunoglobulin components in multiple myeloma and other dysproteinemias [5 1]. Other potential indications include the removal of components other than immunoglobulins. The removal of thrombotic factors has been suggested to explain the effect of plasmapheresis in thrombotic thrombocytopenic purpura (TTP) [25]. Plasmapheresis has also been used to decrease circulating levels of other putative toxic mediators such as bacterial toxins and inflammatory mediators in the treatment or sepsis and multiorgan failure [48]. Infusion of normal plasma may itself have beneficial effects. Indeed, there is evidence that replacement of a deficient plasma component may be the principal mechanism of action of plasmapheresis in TTP [7]. Other theoretical beneficial effects on immune function include depletion of complement products, fibrinogen, and some cytokines, alterations in idiotypic/anti-idiotypic antibody balance, and improvement in reticulo-endothelial system function [9,29,30].